Azelis Group NV (FRA:2R7) Other Long-Term Liabilities: €234 Mil (As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

FRA:2R7 Azelis Group NV FRA:2R7
77 GF Score
Price €12.32
GF Value €16.68
Valuation Modestly Undervalued
! 9 Warning Signs
View Full Analysis

What is Azelis Group NV Other Long-Term Liabilities?

Azelis Group NV FRA:2R7 +0.08% 77 Other Long-Term Liabilities is €234 Mil as of Jun. 2026. GuruFocus rates FRA:2R7 with a GF Score™ of 77/100 and a GF Value™ of €16.68 (Modestly Undervalued). The stock has 9 warning signs investors should review.

Azelis Group NV's other long-term liabilities for the quarter that ended in Jun. 2026 was €234 Mil.

Azelis Group NV's quarterly other long-term liabilities declined from Jun. 2025 (€228 Mil) to Dec. 2025 (€224 Mil) but then increased from Dec. 2025 (€224 Mil) to Jun. 2026 (€234 Mil).

Azelis Group NV's annual other long-term liabilities increased from Dec. 2023 (€221 Mil) to Dec. 2024 (€228 Mil) but then declined from Dec. 2024 (€228 Mil) to Dec. 2025 (€224 Mil).

Azelis Group NV Other Long-Term Liabilities Related Terms

Azelis Group NV Other Long-Term Liabilities Historical Data

* Premium members only.

The historical data trend for Azelis Group NV's Other Long-Term Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Azelis Group NV Other Long-Term Liabilities Chart

Azelis Group NV Annual Data
Trend Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Other Long-Term Liabilities
Get a 7-Day Free Trial 149.10 195.35 221.46 228.42 224.10

Azelis Group NV Semi-Annual Data
Dec18 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25 Jun26
Other Long-Term Liabilities Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 255.69 228.42 227.85 224.10 234.06
FRA:2R7
77GF Score
Azelis Group NV FRA:2R7
Other Long-Term Liabilities is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Azelis Group NV Other Long-Term Liabilities Calculation

Other Long-Term Liabilities are the other liabilities on the balance sheet that do not need to be repaid within the next 12 months, but still need to be repaid over time. For instance, on Wal-Mart's balance sheet, there are items called Long Term obligations under capital leases, deferred income taxes, and redeemable non-controlling interest. These are all Other Long-Term Liabilities.

What does a Other Long-Term Liabilities of €234 Mil mean?
Azelis Group NV (FRA:2R7) has a Other Long-Term Liabilities of €234 Mil as of Jun. 2026. Other long-term liabilities as record on a company's balance sheet not categorized as standard liabilities. View historical data on Azelis Group NV and its competitors.
Is Azelis Group NV's Other Long-Term Liabilities too high?
Azelis Group NV's current Other Long-Term Liabilities is €234 Mil. Overall, Azelis Group NV has a GF Score™ of 77/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Azelis Group NV's Other Long-Term Liabilities compare to LIN and SHW?
Azelis Group NV's Other Long-Term Liabilities of €234 Mil can be compared against companies in the Chemicals industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Other Long-Term Liabilities for a Chemicals company?
A good Other Long-Term Liabilities depends on the Chemicals industry context. However, Other Long-Term Liabilities should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Other Long-Term Liabilities mean?
A high Other Long-Term Liabilities can signal that a stock is expensive relative to its fundamentals. Other long-term liabilities as record on a company's balance sheet not categorized as standard liabilities. View historical data on Azelis Group NV and its competitors. Azelis Group NV's current Other Long-Term Liabilities is €234 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Azelis Group NV stock overvalued right now?
Based on GuruFocus' analysis, Azelis Group NV (FRA:2R7) is currently considered Modestly Undervalued. The stock's GF Value™ is €16.68, compared to a current price of €12.32 — trading 26.1% below its estimated fair value. The current Other Long-Term Liabilities is €234 Mil. Azelis Group NV's overall GF Score™ is 77/100 with 9 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Other Long-Term Liabilities calculated?
Other Long-Term Liabilities is calculated from a company's financial statements. For Azelis Group NV (FRA:2R7), the current Other Long-Term Liabilities is €234 Mil as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Azelis Group NV (FRA:2R7) Overvalued in 2026?

Based on GuruFocus' analysis, Azelis Group NV stock appears to be undervalued. The current stock price of €12.32 is trading 26.1% below its estimated GF Value™ of €16.68. GuruFocus considers Azelis Group NV to be Modestly Undervalued.

Key valuation signals for FRA:2R7:

  • Other Long-Term Liabilities: €234 Mil
  • GF Value™: €16.68 vs. price of €12.32 (26.1% below fair value)
  • GF Score™: 77/100 with 9 warning signs

No single metric tells the full story. See the FRA:2R7 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Azelis Group NV Business Description

Address Posthofbrug 12, Box 6, Berchem, Antwerp, BEL, 2600
Azelis Group NV is an innovation service provider and distributor of speciality chemicals and food ingredients. The Group provides innovation services, multi-product formulations, technical and regulatory expertise, co-creation support, digital solutions, and supply chain services. It serves Food & Nutrition, Animal Nutrition, Personal Care, Home Care & Industrial Cleaning, Pharmaceuticals & Healthcare, Agriculture & Environmental Solutions, Flavours & Fragrances, and Nutraceuticals. The Group operates through four segments: EMEA, Americas, Asia Pacific, and Group holding & other, covering operating companies across Europe, the Middle East and Africa, the United States, Canada, Mexico and South America, Asia, and the Pacific region.
77GF Score

Get the complete analysis for FRA:2R7

Other Long-Term Liabilities is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€12.32
Price
€16.68
GF Value